Destroying latent viral genomes may reduce recurring damage across organ systems
Destroying latent herpes simplex virus genomes in nerve ganglia could reduce recurring damage after antiviral activity ends. Lasting benefit in infection-free animals while the virus remains able to reactivate in infected animals would refute this explanation.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Mobile element or insert
Herpes simplex virus genomes
The genetic material of herpes simplex virus
Where this hypothesis actsLatent infection in nerve ganglia of ageing organisms
Hypotheses on this target 1
Gene editing
Silencing
Excision
Repair
What is proposed
Physically destroy replication-competent viral genomes
With whatNot stated in the record
HowBrief intervention using a switchable system that destroys viral genomes, with verification that the intervention's activity has ceased
Possible result
Possible lasting reduction in recurrent damaging impulses and spontaneous episodes of deterioration
From the recordКраткое воздействие, физически уничтожающее репликационно-компетентные вирусные геномы, прекращает этот источник на длительный срок.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Repeated bouts of infection might keep damaging an ageing body even when earlier injuries remain unrepaired. The unexpected move is to propose a brief treatment that destroys the virus's stored genetic instructions, ending a recurring source of harm without necessarily changing how body systems pass damage between them. This is a proposal generated by the pipeline, not a measured result.
- Dormant herpes simplex virus retains genetic instructions capable of restarting infection.
- Repeated restarts are proposed to send damaging events into several body systems.
- A brief intervention destroys the viral genetic instructions that can support renewed infection.
- After treatment activity ends, the stored infection source remains disabled rather than merely suppressed during treatment.
- Fewer infection-driven events are proposed to reduce repeated damage while earlier tissue injuries and internal damage transmission remain largely unchanged.
A faulty sprinkler keeps soaking several rooms. Removing its water supply could prevent new soaking even while the old water damage remains.
Where the picture breaks: The picture assumes that one identifiable source supplies the repeated harm. The proposal still has to establish that dormant infection plays that role across body systems and that treatment permanently removes its capacity to restart.
- Master questionstep 01 of 04
Ageing processes may reinforce one another, allowing an intervention at one shared cause to benefit several body systems.
Rests on: The goal seeks ways to extend life by targeting a cause shared by several ageing processes.
AssumptionThe starting premise assumes that a shared cause exists whose targeted alteration could benefit several systems; the supplied material does not establish that premise for ageing as a whole.
- Goal pillarstep 02 of 04
The intended output is a collection of life-extension ideas that work through distinct causes.
Rests on: The master question explicitly requests ideas for interventions at shared causes of ageing.
Stated in the chain - Gap questionstep 03 of 04
A brief correction might durably stop damage from reinforcing itself across body systems while leaving substantial existing damage. The proposed condition is crossing ρ(A)=1: a mathematical stability boundary where the spectral radius, the largest absolute eigenvalue of a matrix A describing damage transmission between systems, equals one.
Rests on: The preceding goal requests distinct causal ideas, but supplies no model connecting a brief intervention to this particular stability boundary.
LeapThe chain supplies neither the governing equations nor the connection between measurable biological damage and the proposed matrix. It therefore does not establish why crossing this boundary would produce the stated lasting effect.
- Hypothesisstep 04 of 04
Destroying dormant herpes simplex virus genetic material in nerve ganglia, clusters of nerve-cell bodies, is proposed to reduce recurring damage to blood vessels, immune defences and movement. The proposed benefit comes from reducing incoming damaging events, represented as u(t), and need not change the body's damage-transmission matrix. The designated outcome is SPV_11; SPV_12 requires separate investigation, and neither identifier is defined in the supplied material.
Rests on: The preceding question supplies the brief-intervention, lasting-benefit and residual-damage structure. The endpoint offers removal of an infection source as its mechanism, explicitly departing from the preceding question's requirement to change internal damage transmission.
Stated in the chain
What is carried, and what is not. Screened sources speak to two component ideas: dormant infection can restart, and recurrence can accompany repeated local injury. S7, Nature Communications (2026), reports that removing infected mouse nerve ganglia for study can trigger renewed infection, but does not establish lasting source removal or damage across ageing body systems; S8, Journal of Inflammation Research (2025), describes worsening inflammatory damage with recurrent infection of the cornea, the clear front surface of the eye, but does not establish the proposed effects on blood vessels, immune defences or movement, and no supplied source establishes the sequence end to end.S7S8
Where the reasoning is carried by something unstated · 2
- Master question. The starting premise assumes that a shared cause exists whose targeted alteration could benefit several systems; the supplied material does not establish that premise for ageing as a whole.
- Gap question. The chain supplies neither the governing equations nor the connection between measurable biological damage and the proposed matrix. It therefore does not establish why crossing this boundary would produce the stated lasting effect. Establish the missing link before relying on this step.
How a result here could mislead · 3
- A lasting benefit after a single administration could be credited to permanent source removal while the treatment remains biologically active. The supplied specification explicitly notes that delivery of genetic instructions can sustain production of the acting enzyme, a protein that performs a chemical reaction. What closes it: The proposed switchable treatment must have its activity confirmed to have stopped before benefit is counted as persisting after withdrawal.
- Few recurrent episodes could be mistaken for destruction of the infection source when the animal model rarely produces spontaneous restarts. Conversely, a lack of benefit could reflect failure to remove the source rather than failure of the causal hypothesis. What closes it: The model must demonstrably support renewed infection, and testing must verify loss of the virus's capacity to restart rather than infer it solely from fewer observed episodes. The specification acknowledges limited spontaneous recurrence in mice but supplies no verification procedure.
- Improvement could be attributed to removing infection even if treatment instead changes how tissues respond to damage, a route that would also fit aspects of the competing explanations. What closes it: The specified infected and infection-free groups, confirmed loss of restart capacity, and response to an identical sterile disturbance, meaning a disturbance without infection, must be assessed together. Similar responses to that disturbance alongside fewer spontaneous episodes would support source removal; the supplied material does not define the measurements or how close to baseline counts as unchanged.
What would make this wrong. The proposal explicitly identifies lasting benefit in infection-free animals together with preserved viral restart capacity in infected animals as a result that would refute its explanation. More directly, verified removal of restart capacity without a reduction in recurring damage, after treatment activity ends in a model that previously produced such episodes, would break the proposed link between the infection source and repeated harm across systems.
What it would change. If this held, a shared source of repeated injury could become a candidate for improving several systems without repairing most accumulated damage. Work on broad life-extension interventions would need to distinguish removing incoming harm from weakening the body's internal amplification of harm. Even a successful initial test would not establish longer life, benefit in humans, or passage through the mathematical stability boundary posed earlier in the chain.
Sources read · 9
[Utilization of hybridization in situ and PCR in situ methods to detect latent infection by the wild strain of HSV-1 and by a mutant with reduced reactivation]. · Medycyna doswiadczalna i mikrobiologia · 2002
“We suggest that impaired reactivation of an ICP22 mutant occurs as a result of reduced number of cells with high copy number of viral DNA.”
Does not settle: Источник описывает мышей с мутантом HSV-1 с нарушенной реактивацией в ганглиях. Он не устанавливает физическое уничтожение репликационно-компетентных вирусных геномов, повторное межсистемное повреждение при старении, длительность эффекта или изменения сосудистой, иммунной и двигательной систем.
HSV-1 LAT promotes ocular diseases in the absence of type I IFN responses in sensory neurons. · Journal of virology · 2026
“In the herpes eye model, exposure to external stimuli triggers HSV-1 reactivation in the TG and its retrograde transport back into the cornea via anterograde transport, causing recurrent eye infections ( , ).”
Does not settle: Источник описывает модель герпетического поражения глаза и реактивацию HSV-1 в тройничном ганглии. Он не изучает физическое уничтожение вирусных геномов, длительность такого эффекта, повреждения сосудистой, иммунной или двигательной систем, стареющие организмы, SPV_11 или SPV_12.
Herpetic reactivation during radiotherapy treatment for gynaecological cancers-a retrospective observational study. · Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
“The results implicate that herpesvirus latency in human TG is associated with a local, persistent T cell response, comprising activated late effector memory CD8 + T cells that appear to control HSV-1 latency by noncytolytic pathways.”
Does not settle: Не устанавливает, что повторные реактивации HSV вызывают межсистемное повреждение при старении, что уничтожение латентных вирусных геномов возможно или даёт длительный эффект, а также последствия для сосудистой, иммунной или двигательной систем и SPV_11/SPV_12.
Rituximab and Acute Retinal Necrosis in a Patient with Scleromalacia and Rheumatoid Arthritis. · Ocular immunology and inflammation · 2016
“Although rituximab is a promising biologic agent for the treatment of autoimmune diseases, it bears the risk of reactivation of viral infections, including the onset of acute retinal necrosis.”
Does not settle: Источник описывает риск реактивации вирусной инфекции и острого некроза сетчатки у пациента на ритуксимабе. Он не устанавливает роль латентного вируса простого герпеса в нервных ганглиях, эффекты физического уничтожения вирусных геномов, длительность эффекта или изменения сосудистой, иммунной и двигательной систем.
Recurrent herpetic keratitis induced by laser iridectomy: case report. · Changgeng yi xue za zhi · 1999
“Here we present an unusual case of recurrent herpetic keratitis induced by LI.”
Does not settle: This case report does not establish destruction of latent viral genomes, durable prevention of reactivation, effects in ageing organisms, or reduced recurrent damage in vascular, immune, or motor systems.
Counteracting FOX proteins epigenetically control the herpesvirus lytic-latent balance. · Nature communications · 2026
“Explant of latently infected TG, which mimics neural damage that causes HSV-1 recurrences clinically, can trigger reactivation .”
Does not settle: This source does not test physical destruction of latent viral genomes, durable prevention of reactivation, recurring damage across organ systems, residual tissue damage, or SPV_11/SPV_12. Its reported experiments are in mouse trigeminal ganglia, primary mouse neurons, and cell lines.
IRF6 Enhances IFN-β Expression and Inhibits Viral Replication to Reduce the Severity of Herpetic Stromal Keratitis. · Journal of inflammation research · 2025
“Furthermore, the severity of corneal inflammatory damage worsens with each recurrence, ultimately leading to irreversible vision loss.”
Does not settle: Источник описывает рецидивы и повреждение роговицы при герпетическом стромальном кератите. Он не устанавливает физическое уничтожение латентных вирусных геномов, длительность такого эффекта, последствия в нервных ганглиях или снижение повторных повреждений сосудистой, иммунной и двигательной систем.
Effect of berberine on herpes simplex keratitis through the dimerization of eukaryotic translation initiation factor 2-alpha kinase 2. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
“BBR effectively inhibited HSV-1 replication, alleviated HSK severity, and reduced HSK recurrence risk.”
Does not settle: Источник описывает берберин в клетках роговичного эпителия человека и у мышей с УФ-индуцированной рецидивирующей герпетической кератопатией. Он не устанавливает физическое уничтожение репликационно-компетентных латентных вирусных геномов в нервных ганглиях, длительное прекращение реактиваций, последствия для сосудистой, иммунной или двигательной систем, а также SPV_11 или SPV_12.
Regulation of the innate immune response in human neurons by ICP34.5 maintains herpes simplex virus 1 latency. · bioRxiv : the preprint server for biology · 2025
“IRF3/7 −/− neurons infected with either WT or Δ34.5 showed sustained and spontaneous reactivation regardless of TSA treatment ( ).”
Does not settle: Источник показывает регуляцию реактивации HSV-1 в культурах нейронов человека и тригеминальных ганглиев мышей, но не исследует физическое уничтожение латентных вирусных геномов, длительное прекращение реактиваций, стареющие организмы, повреждение сосудистой, иммунной или двигательной систем либо SPV_11 и SPV_12.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
Can briefly changing one damage-spreading link durably stop aging processes from reinforcing each other while substantial damage remains?
Original wording · exactly as the pipeline generated it
Может ли краткая коррекция одного звена надолго остановить взаимное усиление старения после отмены, если она переводит матрицу межсистемной передачи повреждений через порог устойчивости ρ(A)=1, оставляя значительную часть исходных повреждений?
What this question is asking
The question concerns whether a temporary intervention can leave the body's interacting systems on a persistently less damaging course. It asks whether changing one causal link between those systems can stop their mutual reinforcement after treatment ends, even while much of the original damage remains. The proposed explanation assumes that damage transmission can be represented by a mathematical matrix and that treatment moves it across a boundary separating amplification from decay. The relevant comparison is with the course without that temporary correction, assessing whether reduced damage amplification and slower functional decline persist for months after withdrawal, alongside survival follow-up.
- Damage-spreading link or causal connection
- An influence through which a harmful change in one body system produces a harmful change in another. The question leaves the particular connection unspecified; a causal connection means more than two systems changing together.
- Feedback loop and mutual amplification
- A chain in which a change feeds back to influence its own starting point. In a damaging, self-reinforcing loop, one system worsens another, which then worsens the first.
- Damage-transmission matrix A
- A mathematical table intended to represent how strongly damage in each system affects damage in other systems. Here it is a proposed representation, not a measurement established by the supplied sources.
- Spectral radius ρ(A) and stability boundary
- The spectral radius is the largest absolute size of a matrix's eigenvalues, numbers describing how the matrix scales characteristic patterns of change. In a model that repeatedly applies the same matrix, a value below one makes existing disturbances decay, while a value above one permits amplification. Applying that boundary to an aging body requires assumptions that the supplied sources do not establish.
- Finite treatment course and withdrawal
- A finite course has an endpoint, and withdrawal means stopping the intervention. The question concerns effects that continue after this endpoint, rather than improvement measured only during treatment.
- Functional decline and survival follow-up
- Functional decline means worsening ability of organs or the body to perform their tasks. Survival follow-up tracks whether and how long study subjects remain alive; it is a different outcome from improvement in a particular abnormality.
- Hepatocyte-specific growth hormone receptor ablation
- Hepatocytes are liver cells, and a growth hormone receptor is a cell component that receives a growth-hormone signal. Ablation here means experimental removal of that receptor specifically from these cells, creating the particular mouse system studied in S1.
- Pyruvate dehydrogenase kinase 4 inhibition
- Pyruvate dehydrogenase kinase 4 is an enzyme involved in regulating how cells process fuel. Inhibition means reducing its activity; S1 reports using a drug to do so in living mice.
- Lung–kidney axis
- A collective name for interactions between the lungs and kidneys, rather than a separate anatomical structure or a single connection. S2 describes how damaging changes can travel in both directions within these interactions.
- Thymus and adaptive immunity
- The thymus is an organ involved in developing immune cells used in adaptive immunity, the body's capacity for targeted responses to particular threats. S4 connects deterioration of this organ with weakened immune function and aging elsewhere in the body.
- Oxidative stress
- A state in which reactive oxygen-related chemicals exceed the capacity to control their effects and can damage cell components. S6 discusses it as a possible starting point for persistent changes.
- Epigenetic changes
- Changes in how genetic information is used without changing the underlying genetic sequence. This is a class of regulatory changes; S6 discusses them as a possible route by which earlier stress leaves lasting effects.
- Mitochondrial dysfunction
- Impaired operation of mitochondria, cell structures involved in energy conversion and other cellular processes. S6 discusses this as another possible contributor to lasting effects of stress.
- Metabolic memory
- A term for persistent effects of an earlier disturbance in the body's processing of energy and materials. It names a pattern of lasting influence, not a single established storage mechanism.
- Biological aging
- Age-related changes in the condition and functioning of the body, rather than simply elapsed years. The supplied S6 quotation discusses possible acceleration of this process without supplying a particular measurement.
Aging processes mutually reinforce through a damage-transmission matrix whose stability boundary is ρ(A)=1, and correcting one causal link can cross that boundary while substantial original damage remains.
The assumption concerns organs and body systems passing harmful effects back and forth. It proposes that a table of the strengths of those effects has a calculable boundary between increasing and fading damage, and that changing one connection can move the whole body across it without removing much existing damage. If established, this would supply a reason why a short intervention might have lasting effects.
S2 describes a damaging feedback loop between lungs and kidneys, and S4 describes a self-reinforcing relationship between deterioration of the thymus and aging elsewhere in the body. These support the narrower premise that reciprocal harmful interactions occur. The supplied evidence does not establish an organism-wide damage-transmission matrix, the applicability of ρ(A)=1 as its biological stability boundary, or a one-link intervention that crosses that boundary while leaving substantial damage. This lack of support does not establish that the proposed mechanism is false.S2S4
The same question asked without the part nothing read establishes:
- Can a brief intervention on one damage-spreading link durably reduce mutual worsening between body systems after withdrawal, while substantial damage remains?
- Does improvement from temporarily changing one aging-related interaction persist after treatment ends and extend to body function and survival?
- Mutual amplification remains suppressed after withdrawal Under the proposed mechanism, changing one connection would leave successive rounds of damage transmission weaker even after treatment ends. This would support lasting benefit from a finite course, but remaining damage could still limit function; stopping amplification would not itself establish recovery or longer survival.
- Mutual amplification resumes after withdrawal The intervention would weaken the damaging interaction only temporarily, with the remaining damage again feeding the loop once treatment stops. Improvement during treatment would therefore not establish that a finite course produces a lasting change.
- A local problem improves without stopping mutual amplification Changing the targeted link would improve a particular outcome while other damaging interactions continue. That result would support a limited benefit without establishing the proposed transition in the behavior of the whole body.
If damage in one organ worsens another organ, and that organ sends damaging effects back, an initial problem can become self-reinforcing; the lung–kidney review describes such a loop [S2]. Reducing one connecting influence could, in the question's proposed mechanism, weaken successive rounds of damage. Lasting benefit would require that weakening to persist after the intervention ends, despite the damage still present. Mistaking improvement during treatment for a lasting interruption would overstate what a finite course achieves, while equating reduced amplification with repaired damage would overstate recovery.
Узлы RL-1 и RL-2 описывают обратные связи, память и замедленное восстановление; управляемый переход устойчивости целого организма не установлен.
Устойчивое снижение межсистемного усиления и функционального ухудшения после конечного курса; сохранение эффекта проверяется месяцами и исследованием выживаемости.
Неизвестно, достаточно ли изменения одной причинной связи для длительного затухания повреждений после отмены воздействия.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
У части стареющих организмов возврат межсистемного повреждения поддерживают повторные реактивации латентной инфекции. Краткое воздействие, физически уничтожающее репликационно-компетентные вирусные геномы, прекращает этот источник на длительный срок. Остаточные повреждения тканей сохраняются, но сосудистая, иммунная и двигательная системы получают меньше повторных повреждающих импульсов. Конкретный кандидат для первоначальной проверки представляет собой латентный вирус простого герпеса в нервных ганглиях. В этой гипотезе длительный эффект обусловлен уменьшением входящего воздействия u(t); существенное изменение собственной матрицы передачи A не обязательно. Стабилизируемым результатом служит SPV_11, а возможность улучшить SPV_12 требует отдельного исследования.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
После подтверждённого прекращения активности противовирусного вмешательства длительное улучшение появляется преимущественно у животных с исходной латентной инфекцией и зависит от утраты способности вируса реактивироваться. В свободной от исследуемой инфекции группе сопоставимого эффекта нет. Ответ на одинаковое стерильное возмущение и оценённые коэффициенты A остаются близкими к исходным, тогда как число спонтанных эпизодов ухудшения уменьшается. Восстановление инфекции возвращает эти эпизоды. Длительная польза у свободных от инфекции животных при сохранении способности вируса реактивироваться в инфицированной группе опровергает предложенное объяснение.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable group differences, changes relative to baseline, reversal upon restoration of infection, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Существует доказательство принципа уменьшения латентного вирусного резервуара у мышей. Однако однократное введение генетического вектора может сопровождаться длительной экспрессией фермента, поэтому оно не доказывает эффект после отмены. Для данного теста нужна выключаемая система и проверка прекращения её активности. Модель должна воспроизводить реактивацию: спонтанная реактивация вируса простого герпеса у мышей ограничена, что сужает переносимость результатов.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
После подтверждённого прекращения активности противовирусного вмешательства длительное улучшение появляется преимущественно у животных с исходной латентной инфекцией и зависит от утраты способности вируса реактивироваться. В свободной от исследуемой инфекции группе сопоставимого эффекта нет. Ответ на одинаковое стерильное возмущение и оценённые коэффициенты A остаются близкими к исходным, тогда как число спонтанных эпизодов ухудшения уменьшается. Восстановление инфекции возвращает эти эпизоды. Длительная польза у свободных от инфекции животных при сохранении способности вируса реактивироваться в инфицированной группе опровергает предложенное объяснение.
- Rival 01 of 03What would separate them
Polymerase theta repair may extend life by sealing persistent genetic breaks with mutations predicts: Через 1, 3 и 6 месяцев после подтверждённого прекращения активности вмешательства сохраняются новые участки соединения ДНК, уменьшается число физических разрывов и ослабевает передача повреждения между системами. При этом число вставок и делеций увеличивается. Каталитически неактивная полимераза эффекта не даёт. Краткое подавление воспалительной секреции с сопоставимым ранним улучшением функций уступает по длительности пользы. Решающий результат: улучшение сосудистой реактивности, мышечной функции и функции печени вместе с увеличением оставшейся продолжительности жизни при возросшей мутационной нагрузке. Сохранение пользы при отсутствии новых соединений ДНК опровергает предложенный механизм.
- Rival 02 of 03What would separate them
Briefly lowering cell surface tension may let cells swap neighbors and durably ease tissue stress predicts: Короткое воздействие даёт длительную пользу только в участках, где произошли обмены клеточными соседями. При одинаковом снижении кортикального натяжения геометрическое ограничение перестановок устраняет последующий устойчивый эффект. После отмены воздействия натяжение возвращается к исходному уровню, но новая карта соседств и уменьшенное остаточное напряжение сохраняются. Число мутаций, вирусная нагрузка и распределение белков между растворимой фракцией и включениями могут остаться прежними. Воспроизведение исходной геометрии в тканевой модели возвращает повреждающую секрецию. Длительная польза при неизменной карте соседств опровергает эту гипотезу.
- Rival 03 of 03Trapping misfolded proteins in lasting inclusions may reduce damage across organs
Not yet published.
What would separate themTrapping misfolded proteins in lasting inclusions may reduce damage across organs predicts: После отмены воздействия уменьшается растворимая токсичная фракция, увеличивается доля белка во включениях и сохраняется функциональная польза. Метка исходного белкового груза подтверждает его длительное удержание. Избирательное высвобождение того же груза из включений возвращает повреждающий эффект при сопоставимой общей массе белка; контроль самого воздействия исключает повреждение от процедуры высвобождения. Устойчивое улучшение при полном предотвращении образования включений опровергает механизм. Гипотеза также предсказывает возможную потерю пользы, если последующая нагрузка вызывает распад включений.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.